MetaCap

SAB Biotherapeutics Statistics

NASDAQ: SABSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.81-0.10 (-3.44%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SAB Biotherapeutics by the numbers

SAB Biotherapeutics has a market capitalization of $253.1 million based on 90.09M shares outstanding. With trailing EPS of $-1.35, SAB Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.4% below its 50-day average and 21.9% below its 200-day average.

Average daily trading volume is 633.60K shares, or about $1.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SABS valuation vs. peer median

SABS compared with the median of 8 peer companies
MetricSABSPeer medianDifference
Market cap$253.15M$254.98M-1%
Avg. volume633.60K1.44M-56%

Peer median across 8 companies: EDIT, EIKN, OCGN, LXEO, PLX, AUTL, AGMB, KYTX.

Valuation

Price and trading

Previous close
2.91
Open
2.79
Day range
2.64 – 2.88
52-week range
2.44 – 5.15
52-week change
-28.86%
Beta
—
Volume
874.57K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
253.15M
Forward Pe
-2.98
Eps
-1.35
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.15
Week52 Low
2.44
Avg Volume
633.60K
Shares Outstanding
90.09M
Ma50
3.07
Ma200
3.60
Earnings Date
Nov 5, 2026
Pct From52w High
-45.44%
Pct From52w Low
15.16%

Related